OphtiMed Rx Israeli Company
OphtiMed Rx is developing a novel molecular therapy for dry age-related macular degeneration (AMD), a common eye disease leading to blindness. The company’s treatment protects retinal cells from senescence (cellular aging) and can halt the progression of dry AMD.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Afula, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/ophtimed-rx
External links are provided for reference and verification purposes.